Irinotecan Mylan 20 mg / ml concentrate for solution for infusion
- Licence status
- Withdrawn: 26/04/2021
- Active substances
- Irinotecan hydrochloride trihydrate
- Dosage Form
- Concentrate for solution for infusion
- Licence number
- PA0577/234/001
- Licence holder
- McDermott Laboratories Ltd., T/A Gerard Laboratories
Product documents
- Package Leaflet
- Summary of Product Characteristics
- Public Assessment Report
Licence information
- ATC code
- L01XX Other antineoplastic agents, L01XX19 irinotecan
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- Medicinal product subject to restricted medical prescription (See: Summary of Product Characteristics, section 4.4).
- Marketing availability
- Not marketed
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 07/07/2017